Smith Group Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-20,967
| Closed | -$92K | – | 450 |
|
|
2018
Q3 | $92K | Hold |
20,967
| – | – | ﹤0.01% | 276 |
|
|
2018
Q2 | $129K | Hold |
20,967
| – | – | ﹤0.01% | 267 |
|
|
2018
Q1 | $153K | Sell |
20,967
-733
| -3% | -$5.35K | 0.01% | 271 |
|
|
2017
Q4 | $178K | Hold |
21,700
| – | – | 0.01% | 266 |
|
|
2017
Q3 | $228K | Sell |
21,700
-710
| -3% | -$7.46K | 0.01% | 254 |
|
|
2017
Q2 | $247K | Sell |
22,410
-10,180
| -31% | -$112K | 0.01% | 259 |
|
|
2017
Q1 | $315K | Hold |
32,590
| – | – | 0.01% | 222 |
|
|
2016
Q4 | $339K | Buy |
32,590
+2,160
| +7% | +$22.5K | 0.01% | 214 |
|
|
2016
Q3 | $377K | Buy |
30,430
+650
| +2% | +$8.05K | 0.01% | 201 |
|
|
2016
Q2 | $320K | Buy |
+29,780
| New | +$320K | 0.01% | 217 |
|